Wall Street analysts expect that CRH Medical Corporation (NASDAQ:CRHM) will announce $31.27 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for CRH Medical’s earnings, with estimates ranging from $31.10 million to $31.50 million. CRH Medical reported sales of $28.73 million during the same quarter last year, which would suggest a positive year over year growth rate of 8.8%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, October 30th.
According to Zacks, analysts expect that CRH Medical will report full year sales of $128.04 million for the current financial year, with estimates ranging from $124.30 million to $131.00 million. For the next year, analysts anticipate that the company will report sales of $142.64 million, with estimates ranging from $135.20 million to $151.80 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow CRH Medical.
CRH Medical (NASDAQ:CRHM) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.01. The company had revenue of $30.48 million for the quarter, compared to analyst estimates of $29.50 million.
NASDAQ:CRHM traded down $0.01 during trading hours on Thursday, reaching $3.25. 11,331 shares of the company were exchanged, compared to its average volume of 65,759. CRH Medical has a 1-year low of $2.51 and a 1-year high of $4.50. The firm has a 50 day moving average of $2.90.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Read More: Bar Chart
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.